Steven Bartlett

News

Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.